Dental Implants After Head and Neck Radiotherapy: From Chronological Waiting Rules to Implant-Bed-Specific Risk Stratification.

Dental implant-supported rehabilitation is a key component of functional survivorship care for patients with head and neck cancer (HNC) treated with radiotherapy (RT). Despite its importance, implant outcomes in this population are frequently interpreted through simplified paradigms such as irradiated versus non-irradiated status, prescribed tumor dose, pre-RT versus post-RT placement, and arbitrary post-RT waiting intervals. This narrative review proposes a radiobiology-informed, implant-bed-specific framework for assessing implant viability following HNC RT. The biologically relevant exposure is best defined as the localized radiation dose delivered to the implant bed, considered in conjunction with fractionation, equivalent dose in 2-Gy fractions, recipient substrate, soft-tissue condition, prosthetic loading, systemic host factors, and late toxicity risk. Distinctions among early osseointegration, implant survival, implant success, prosthetic rehabilitation, and patient-centered functional benefit are essential, as retained implants do not necessarily equate to durable or meaningful rehabilitation. Post-RT timing should be understood as a contextual variable rather than a universal chronological determinant, since longer intervals do not inherently indicate progressive biological recovery and may be confounded by survivor and clinician selection. Future research should prioritize implant-bed-specific dosimetry, continuous modeling of dose and timing, standardized outcome measures, cluster-adjusted statistical approaches, time-to-event analyses, and explicit reporting of osteoradionecrosis as a distinct implant-relevant late toxicity endpoint. Shifting from chronological waiting rules to implant-bed-specific risk stratification may enhance the safety, interpretability, and clinical relevance of dental implant rehabilitation following HNC RT.